收藏切换
Practice and Reflections on Investigator-Initiated Trial Approval Management with a Focus on Risk Prevention and Control
收藏切换
PDF
Zhen LIU, Junyu HU, Yucui TIAN, Rui JU, Yinmei DAI*
Chinese Pharmaceutical Journal | 2025, 60(1) : 100 - 104
Less
收藏切换
Chinese Pharmaceutical Journal | 2025, 60(1): 100-104
Practice and Reflections on Investigator-Initiated Trial Approval Management with a Focus on Risk Prevention and Control
Full
Zhen LIU, Junyu HU, Yucui TIAN, Rui JU, Yinmei DAI*
Affiliations
  • GCP Office, Beijing Maternal and Child Health Care Hospital, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China
Published: 2025-01-08 doi: 10.11669/cpj.2025.01.014
Outline
收藏切换

OBJECTIVE To explore investigator-initiated trial(IIT) approval management with a focus on risk prevention and control in the absence of guidelines for IIT approval management. METHODS Through a combination of literature review and practical experiences, this study analyzed the challenges encountered in the approval process and explored its potential risks, outlined the approval process following the promulgation of the management regulations, summarized its key aspects, and assessed the significance of the approval process with a focus on risk prevention and control.RESULTS There exist inherent risks in areas such as research design, participant protection, research team dynamics, and research funding. The authors advocate for the implementation of compliance review, peer expert evaluation, and a hierarchical approval review by expert technical committee, emphasizing scrutiny of scientific validity, feasibility, and funding adequacy. CONCLUSION The proactive identification and prevention of potential risks are highlighted as crucial benefits of the approval management. Centralized management of IIT projects, development of data management platforms, and diversification of funding channels to enhance risk mitigation should be further explored.

investigator-initiated trials  /  risk control  /  approval management  /  data quality  /  scientific research management
Zhen LIU, Junyu HU, Yucui TIAN, Rui JU, Yinmei DAI. Practice and Reflections on Investigator-Initiated Trial Approval Management with a Focus on Risk Prevention and Control[J]. Chinese Pharmaceutical Journal, 2025 , 60 (1) : 100 -104 . DOI: 10.11669/cpj.2025.01.014
Year 2025 volume 60 Issue 1
PDF
178
83
Cite this Article
BibTeX
Article Info
doi: 10.11669/cpj.2025.01.014
  • Receive Date:2024-03-13
  • Online Date:2025-11-24
  • Published:2025-01-08
Article Data
Affiliations
History
  • Received:2024-03-13
Funding
Affiliations
    GCP Office, Beijing Maternal and Child Health Care Hospital, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China
References
Share
https://castjournals.cast.org.cn/joweb/zgyxzz/EN/10.11669/cpj.2025.01.014
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT